ea0020p489 | Obesity and Metabolism | ECE2009
Diamanti-Kandarakis Evanthia
, Christakou Charikleia
, Piperi Chistina
, Kandaraki Eleni
, Katsikis Ilias
, Adamopoulos Christos
, Papavasiliou Athanasios G
, Panidis Dimitrios
Background: Polycystic ovary syndrome (PCOS) is associated with obesity and insulin resistance, two major contributors to cardiovascular risk. Even in the absence of detectable insulin resistance, lean, non-diabetic PCOS women demonstrate increased circulating levels of advanced glycated end products (AGEs), known proatherogenic molecules. This adverse cardiovascular risk profile should be considered in the syndromes management.Objective: To invest...